Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review
1Campbell University School of Pharmacy, Buies Creek, NC, USA.
Objective:
To describe a patient with subtherapeutic phenytoin concentrations and to review the literature regarding a possible interaction between phenytoin and chemotherapeutic agents as well as dexamethasone.
Case Summary:
A 29-year-old white man with brain metastases secondary to malignant melanoma consistently had suboptimal phenytoin concentrations while receiving chemotherapy consisting of cisplatin, carmustine, dacarbazine, and tamoxifen. In addition, this patient received dexamethasone, which may have influenced his phenytoin concentrations.
Data Sources And Study Selection:
Case reports were identified through a MEDLINE search and by cross referencing the articles identified.
Discussion:
The available literature addressing suboptimal phenytoin concentrations in the setting of chemotherapy is reviewed. Aggressive dosing of phenytoin may be required to achieve therapeutic concentrations in patients who are concurrently receiving chemotherapy and/or dexamethasone, especially in patients who fall outside the predictive pharmacokinetic model for phenytoin.
Conclusions:
Subtherapeutic phenytoin concentrations may be decreased secondary to several proposed mechanisms: (1) the patient falls outside the predicted pharmacokinetic population parameters for phenytoin, (2) phenytoin absorption is decreased secondary to chemotherapy-induced gastrointestinal toxicity, and (3) metabolism of phenytoin is increased secondary to chemotherapy agents.
Insights
Patients receiving chemotherapy and dexamethasone may require higher phenytoin doses due to subtherapeutic drug concentrations. This review explores potential drug interactions affecting phenytoin levels in cancer patients.
Area of Science:
- Pharmacology
- Oncology
- Drug Interactions
Background:
- Phenytoin is an anticonvulsant medication.
- Chemotherapy and dexamethasone are commonly used in cancer treatment.
- Subtherapeutic drug levels can impact treatment efficacy.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Idiosyncratic Reactions
Drug toxicity: Drug–Drug Interaction
